Format

Send to

Choose Destination
Exp Cell Res. 2016 Sep 10;347(1):65-73. doi: 10.1016/j.yexcr.2016.07.011. Epub 2016 Jul 15.

LRRC14 attenuates Toll-like receptor-mediated NF-κB signaling through disruption of IKK complex.

Author information

1
Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
2
Key Laboratory of Gene Engineering of the Ministry of Education, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, China.
3
Hangzhou Normal University, Hang Zhou, China.
4
Key Laboratory of Gene Engineering of the Ministry of Education, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, China. Electronic address: cuij5@mail.sysu.edu.cn.

Abstract

Activation of NF-κB signaling plays pivotal roles in innate immune responses against pathogens. It requires strict control to avert inflammatory diseases. However, the mechanisms underlying this tight regulation are not completely understood. Here, we identified LRRC14, a novel member of LRR (leucine-rich repeat) protein family, as a negative regulator in TLR signaling. Expression of LRRC14 resulted in decreased activation of NF-κB, whereas knockdown of LRRC14 enhanced NF-κB activation as well as the production of inflammatory cytokines. Mechanistically, LRRC14 bound to HLH domain of IKKβ to block its interaction with NEMO and thereby inhibiting the phosphorylation of IKKβ and NF-κB activation. In addition, our data showed that TLR signaling led to lower expression of LRRC14. Together, LRRC14 may function as a checkpoint to prevent overzealous inflammation.

KEYWORDS:

IKKβ; Leucine-rich repeat; NF-κB; Phosphorylation; Toll-like receptor

PMID:
27426725
DOI:
10.1016/j.yexcr.2016.07.011
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center